CD73 participates in cellular multiresistance program and protects against TRAIL-induced apoptosis.
about
Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis.Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia.Cellular function and molecular structure of ecto-nucleotidases.Graft-versus-host disease is enhanced by selective CD73 blockade in miceAlternative splicing of human NT5E in cirrhosis and hepatocellular carcinoma produces a negative regulator of ecto-5'-nucleotidase (CD73).Ecto-5'-nucleotidase expression is associated with the progression of renal cell carcinoma.CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell deathNT5E CpG island methylation is a favourable breast cancer biomarker.Antiproliferative and proapoptotic effects of a pyrrole containing arylthioindole in human Jurkat leukemia cell line and multidrug-resistant Jurkat/A4 cellsTargeting CD73 in the tumor microenvironment with MEDI9447.Colony-stimulating factor 2 inhibits induction of apoptosis in the bovine preimplantation embryo.Up-regulated Ectonucleotidases in Fas-Associated Death Domain Protein- and Receptor-Interacting Protein Kinase 1-Deficient Jurkat Leukemia Cells Counteract Extracellular ATP/AMP Accumulation via Pannexin-1 Channels during Chemotherapeutic Drug-InducCD73 represses pro-inflammatory responses in human endothelial cells.RNAi-mediated CD73 suppression induces apoptosis and cell-cycle arrest in human breast cancer cells.Extracellular Adenosine Production by ecto-5'-Nucleotidase (CD73) Enhances Radiation-Induced Lung FibrosisEviction from the sanctuary: Development of targeted therapy against cell adhesion molecules in acute lymphoblastic leukemia.Targeting the Adenosinergic Axis in Chronic Lymphocytic Leukemia: A Way to Disrupt the Tumor Niche?CD73 Regulates Stemness and Epithelial-Mesenchymal Transition in Ovarian Cancer-Initiating Cells.Potential prognostic biomarker CD73 regulates epidermal growth factor receptor expression in human breast cancer.Adenosine signaling mediates hypoxic responses in the chronic lymphocytic leukemia microenvironment
P2860
Q33667612-58734967-26BF-4FEE-B2D5-531E56876CC1Q33680280-8B6232F4-6C4A-4365-8999-F08920AC2D94Q34031794-336FEDB0-3781-4EB8-8FD5-2EDF29944D84Q34631798-3BBD5314-34C5-4687-99A3-05BA0B99EC5DQ34680354-3FCAEA2D-1FD4-49F0-9619-5F7CC5FA6F82Q35758898-99E0D99B-5F09-4303-9B0F-D535BE6E21C4Q35930211-D54E43B2-6352-4169-B392-616B2303F041Q36075236-695C8622-136B-4ADC-A0EC-1DA87D195DFAQ36843796-70D9E387-4ED9-4264-9B29-22446B975834Q37224639-58E0B158-A0FD-4FEE-8B33-CC9FB0309DEEQ38503733-D2C800DB-1B47-4672-906B-345A97491278Q38705263-4E5F5546-BF51-4E07-958E-83CC54C730CAQ39437258-65EDB37B-6029-4454-B6FB-45CC45C9ECB9Q39651040-8D29DA35-B814-4406-BD84-B5B66AD8DF14Q40775402-5B02DC4E-3DB9-4802-97E2-F9A1E63E6A67Q47783708-A2FF98A7-C41B-44EA-BC50-6EFE8E7875D6Q52323624-92C2CDE9-622D-47E6-B9F2-1E161AAB915AQ52649982-4A495D7C-5688-46C5-A855-D56433706B6BQ54476094-621FF662-5617-42DD-9CEF-E7F58D61D27FQ56962743-B3B037A0-74B2-42A4-8894-55F8AEEC7FBC
P2860
CD73 participates in cellular multiresistance program and protects against TRAIL-induced apoptosis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
CD73 participates in cellular ...... ainst TRAIL-induced apoptosis.
@en
type
label
CD73 participates in cellular ...... ainst TRAIL-induced apoptosis.
@en
prefLabel
CD73 participates in cellular ...... ainst TRAIL-induced apoptosis.
@en
P2093
P2860
P1476
CD73 participates in cellular ...... ainst TRAIL-induced apoptosis.
@en
P2093
Alice Sokolovskaya
Andrey Mikhailov
Dmitry Blokhin
Gennady G Yegutkin
Hanne Amdahl
Hideo Yagita
John E Eriksson
Linda F Thompson
Riitta Lahesmaa
P2860
P304
P356
10.4049/JIMMUNOL.181.1.464
P407
P577
2008-07-01T00:00:00Z